The Influence of Antisense Oligonucleotide Length on Dystrophin Exon Skipping
Open Access
- 1 January 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (1) , 157-166
- https://doi.org/10.1038/sj.mt.6300006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Dystrophin and mutations: one gene, several proteins, multiple phenotypesThe Lancet Neurology, 2003
- Advances in Duchenne muscular dystrophy gene therapyNature Reviews Genetics, 2003
- Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotidesNeuromuscular Disorders, 1999
- Becker muscular dystrophy with onset after 60 yearsNeurology, 1994
- Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.Proceedings of the National Academy of Sciences, 1993
- Exon Structure of the Human Dystrophin GeneGenomics, 1993
- Very mild muscular dystrophy associated with the deletion of 46% of dystrophinNature, 1990
- Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy geneTrends in Biochemical Sciences, 1989
- An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locusGenomics, 1988
- Chronic intestinal pseudoobstruction as a complication of Duchenne's muscular dystrophyGastroenterology, 1986